Anand Nandakumar (our CEO) and Dr. James Dixon (inventor) wrote an article on the use of non-viral gene therapies for bone regeneration.
This has been published by Innovations in Pharmaceutical Technology.
Click here to read the article.
Innovations in Pharmaceutical Technology, Spring 2024, pages 30-34. © Samedan Ltd